中文
ENGLISH
Home
About Us
News
Products
EHS Management
Recruitment
Contact Us
中文版
Search
Categories
Apis and advanced intermediates
Calaglizin and intermediates
Dapagliflozin and intermediates
Eparezin and intermediates
Sotagliflozin and intermediates
Ipragliflozin and intermediates
Ertugliflozin and intermediates
Berglein and intermediates
Toglizin and intermediates
Rusotinib and intermediates
Upatinib and intermediates
Terezolamide phosphate and intermediates
Features intermediates
Rivaroxaban intermediate
Ruxolitinib intermediate
Tofacitinib intermediate
Sotagliflozin intermediate
Ipragliflozin intermediate
Ertugliflozin intermediate
Repaglinide intermediate
Canagliflozin hemihydrate Intermediates
Riociguat intermediate
Vericiguat intermediate
Empagliflozin intermediate
Baricitinib intermediate
Abrocitinib intermediate
Filgotinib intermediate
Dapagliflozin propanediol monohydrate intermediate
Crizotinib intermediate
Larotrectinib intermediate
Lorlatinib intermediate
Asciminib
Suvorexant
Rasagiline
Tigecycline
Torezolid
R&D projects
Elagolix
Filgotinib
Baloxavir
Imeglimin
Upadacitinib
Asciminb
Custom production
Link:
Lian Chuang Biomedicine
Products
Classification:
Larotrectinib intermediate
Classification
(S)-3-吡咯烷醇
Cas No.:
100243-39-8
Molecular Formula::
C
4
H
9
NO
Molecular Weight::
87.12
Molecular Structure:
Memo:
版权所有 © 2018 安微森吉制药有限公司
后台管理